An Information and Advocacy Toolkit for Patients' Organizations
This toolkit provides patients’ organizations with up-to-date, evidence-based information on the science, technology and regulatory information relevant to biologic originator and thier biosimilar medicines, as well as tips on advocacy.
We believe that patients should be aware of what biologic originator and biosimilar medicines are and what the implications of their increasing availability will mean to them. We hope that these resources will help patient advocates to make informed judgments on the value of biologic originator and biosimilar medicines and actively engage in debate and discussion.
Biologics Medicines Toolkit 2017
The development of this Toolkit was a joint research effort by the International Alliance of Patients’ Organizations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) with the educational grant support of Roche and Amgen.
Free for patients' groups
This toolkit is freely available to all patients' organizations across the world, whether an IAPO member or not. If you are a patients' organization, and would like a printed copy, please complete the order form and send back to IAPO via email at email@example.com.